Veradermics says it has made a big discovery that could help with hair loss.

Oct 19, 2026, 1:36 PM ETTrialRead the original at Benzinga

Good for MANE

Veradermics said its Phase 3 study met all its goals, and hair counts rose more than with placebo. The pill is still experimental and needs FDA approval, but the results support its path toward a new treatment.

MANE · Veradermics Incorporated

AI read · Good for MANE

The AI's read

These results give Veradermics stronger evidence that its pill can help treat hair loss. The hair-count gains exceeded placebo, and the study reported no treatment-related serious or heart-related events. The pill is still experimental, and further trial results and FDA approval are ahead.

Get alerts for MANE

Follow Veradermics Incorporated (MANE) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for MANE

Free on the App Store and Google Play, or on the web.